Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $2.67 USD
Change Today +0.12 / 4.71%
Volume 8.3K
CCEL On Other Exchanges
Symbol
Exchange
OTC US
As of 8:10 PM 04/21/15 All times are local (Market data is delayed by at least 15 minutes).

cryo-cell intl inc (CCEL) Snapshot

Open
$2.55
Previous Close
$2.55
Day High
$2.67
Day Low
$2.55
52 Week High
10/1/14 - $3.50
52 Week Low
04/29/14 - $2.05
Market Cap
26.5M
Average Volume 10 Days
7.8K
EPS TTM
$0.04
Shares Outstanding
9.9M
EX-Date
--
P/E TM
64.2x
Dividend
--
Dividend Yield
--
Current Stock Chart for CRYO-CELL INTL INC (CCEL)

Related News

No related news articles were found.

cryo-cell intl inc (CCEL) Related Businessweek News

No Related Businessweek News Found

cryo-cell intl inc (CCEL) Details

Cryo-Cell International, Inc. engages in cellular processing and cryogenic cellular storage with focus on the collection and preservation of umbilical cord blood stem cells for family use. The company offers advanced cord tissue service that stores a section of the umbilical cord tissue, which is a source of mesenchymal stem cells that are used in regenerative medicine for a range of conditions, including heart, kidney, ALS, wound healing, and auto-immune diseases. It stores approximately 300,000 cord blood and cord tissue specimens worldwide. The company markets its cord blood stem cell preservation services directly to expectant parents, as well as by distributing information through obstetricians, pediatricians, childbirth educators, certified nurse-midwives, and other related healthcare professionals. Cryo-Cell International, Inc. was founded in 1989 and is headquartered in Oldsmar, Florida.

66 Employees
Last Reported Date: 03/2/15
Founded in 1989

cryo-cell intl inc (CCEL) Top Compensated Officers

Chairman and Co-Chief Executive Officer
Total Annual Compensation: $485.6K
Co-Chief Executive Officer and Director
Total Annual Compensation: $411.1K
Chief Financial Officer and Vice President of...
Total Annual Compensation: $177.9K
Chief Information Officer
Total Annual Compensation: $165.0K
Compensation as of Fiscal Year 2014.

cryo-cell intl inc (CCEL) Key Developments

Cryo-Cell International, Inc. Reports Consolidated Earnings Results for the First Quarter Ended February 28, 2015

Cryo-Cell International, Inc. reported consolidated earnings results for the first quarter ended February 28, 2015. Consolidated revenues were approximately $4.8 million compared to approximately $5.3 million for the first quarter of fiscal 2014, a 9% decrease. The revenues for the first quarter of fiscal 2015 consisted of approximately $4.7 million in processing and storage fees and approximately $169,000 in licensee income compared to approximately $4.4 million in processing and storage fees and approximately $963,000 in licensee income for the first quarter of fiscal 2014. The company reported net income of approximately $286,000, or $0.03 per basic and diluted share, compared to net income of approximately $397,000, or $0.04 per basic and diluted share for the three months ended February 28, 2014. The decrease in net income for the three months ended February 28, 2015 principally resulted from the 9% decrease in revenues. The decrease in revenue was primarily attributable to an 82% decrease in licensee income offset by a 7% increase in processing and storage fees. This was partially offset by a 5% decrease in cost of sales and a 7% decrease in selling, general and administrative expenses. Cash provided by operations were $329,000 and approximately $23,000 of cash was used to purchase property and equipment.

Cryo-Cell International, Inc. Reports Consolidated Earnings Results for the Year Ended November 30, 2014

Cryo-Cell International, Inc. reported consolidated earnings results for the year ended November 30, 2014. For the period, the company reported consolidated revenues were approximately $20.1 million compared to approximately $19.0 million for fiscal 2013. The company reported net income in fiscal 2014 of $554,000, or $0.05 per basic and diluted share, compared to net income of $27,000 or $0.00 per basic and diluted share in fiscal 2013. Net income for the year ended November 30, 2014 principally resulted from a 6% increase in revenues and a settlement from litigation.

Cryo-Cell International, Inc. Announces Consolidated Earnings Results for the Third Quarter Ended August 31, 2014

Cryo-Cell International, Inc. announced consolidated earnings results for the third quarter ended August 31, 2014. Consolidated revenues for the third quarter of fiscal 2014 were approximately $4.9 million compared to approximately $4.8 million for the third quarter of fiscal 2013. Net income for the three months ended August 31, 2014 of approximately $237,000, or $0.02 per basic and diluted share, compared to net income of approximately $194,000, or $0.02 per basic and diluted share for the three months ended August 31, 2013. The increase in net income for the three months ended August 31, 2014 is partially a result of a 2% increase in revenues and a settlement received from litigation.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CCEL:US $2.67 USD +0.12

CCEL Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Bionet Corp 42.20 TWD +0.50
CryoLife Inc $10.19 USD +0.04
Osiris Therapeutics Inc $16.45 USD +0.10
Smith & Nephew PLC 1,166 GBp +8.00
Vitrolife AB kr155.00 SEK +3.50
View Industry Companies
 

Industry Analysis

CCEL

Industry Average

Valuation CCEL Industry Range
Price/Earnings 59.1x
Price/Sales 1.3x
Price/Book NM Not Meaningful
Price/Cash Flow 53.0x
TEV/Sales 1.4x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CRYO-CELL INTL INC, please visit www.cryo-cell.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.